Recruiting

Behavioral Pain Intervention for Older Cancer Patients

This randomized controlled trial examines a 1-session, telehealth pain coping skills training (PCST) protocol with five 15-minute maintenance calls (Brief PCST-Community) adapted for women with breast cancer in medically underserved areas. Pain, health-related quality of life, and self-efficacy for pain management will be assessed at baseline and 10 and 15 weeks later.

ClinicalTrials.gov IDNCT07300995

PhaseNA

Enrollment168

SponsorWeill Medical College of Cornell University

Age55 Years

SexFEMALE

I'm interested View official listing

Conditions studied

Breast Cancer

About this study

Interventions

Behavioral: Pain Coping Skills Training (PCST) — Behavioral pain intervention delivered via telehealth.

Primary outcomes

Pain severity as measured by the Brief Pain Inventory (BPI) (Baseline, 10-week assessment, 15-week assessment)
Pain interference as measured by the Brief Pain Inventory (BPI) (Baseline, 10-week assessment, 15-week assessment)
Health Related Quality of Life (HR-QOL) as measured by the Patient Reported Outcomes Measurement Information System (PROMIS-29) - Physical Function (Baseline, 10-week assessment, 15-week assessment)
Health Related Quality of Life (HR-QOL) as measured by the Patient Reported Outcomes Measurement Information System (PROMIS-29) - Mental Health (Baseline, 10-week assessment, 15-week assessment)

Eligibility information

Inclusion Criteria: * Receiving cancer care at a Duke Cancer Network (DCN) clinic * Stage I-IV breast cancer * Self-reported pain on at least 10 days in the last month and pain rating of worst pain of 4 or greater on a 0-10 scale in the last week * Biologically female * Greater than or equal to 55 years old * Ability to speak and read English * Hearing and vision that allows for successful completion of videoconferencing and phone session Exclusion Criteria: * Participation in the last 6 months in a pain coping skills training program

Study locations

Duke Cancer Network, Durham, North Carolina 27713 United States

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.